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Abstract
MicroRNAs (miRNAs) are small non-coding RNAs that associate with Argonaute proteins to regulate gene expression at
the post-transcriptional level in the cytoplasm. However, recent studies have reported that some miRNAs localize to and
function in other cellular compartments. Mitochondria harbour their own genetic system that may be a potential site for
miRNA mediated post-transcriptional regulation. We aimed at investigating whether nuclear-encoded miRNAs can localize
to and function in human mitochondria. To enable identification of mitochondrial-enriched miRNAs, we profiled the
mitochondrial and cytosolic RNA fractions from the same HeLa cells by miRNA microarray analysis. Mitochondria were
purified using a combination of cell fractionation and immunoisolation, and assessed for the lack of protein and RNA
contaminants. We found 57 miRNAs differentially expressed in HeLa mitochondria and cytosol. Of these 57, a signature of
13 nuclear-encoded miRNAs was reproducibly enriched in mitochondrial RNA and validated by RT-PCR for hsa-miR-494,
hsa-miR-1275 and hsa-miR-1974. The significance of their mitochondrial localization was investigated by characterizing
their genomic context, cross-species conservation and instrinsic features such as their size and thermodynamic
parameters. Interestingly, the specificities of mitochondrial versus cytosolic miRNAs were underlined by significantly
different structural and thermodynamic parameters. Computational targeting analysis of most mitochondrial miRNAs
revealed not only nuclear but also mitochondrial-encoded targets. The functional relevance of miRNAs in mitochondria
was supported by the finding of Argonaute 2 localization to mitochondria revealed by immunoblotting and confocal
microscopy, and further validated by the co-immunoprecipitation of the mitochondrial transcript COX3. This study
provides the first comprehensive view of the localization of RNA interference components to the mitochondria. Our data
outline the molecular bases for a novel layer of crosstalk between nucleus and mitochondria through a specific subset of
human miRNAs that we termed ‘mitomiRs’.
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Introduction
Mitochondria are eukaryotic organelles that maintain and
express their own genome, known as the mitochondrial DNA
(mtDNA). The transcription and translation of the mtDNA as well
as the processing of mitochondrial transcripts requires the
involvement of several types of non-coding RNAs (ncRNA),
which can be either mitochondrially encoded or transcribed within
the nucleus and subsequently localized to mitochondria [1]. In
human mitochondria, the full set of mitochondrial transfer RNAs
(tRNAs) and two ribosomal RNAs (rRNAs), namely the 12S and
16S rRNAs, are transcribed from the mtDNA [2], while the RNA
moiety of the RNase MRP enzymes [3,4,5], the 5S rRNA [6,7],
and two species of tRNA
Gln [8] are all RNAs delivered into
mitochondria from the nucleus.
Among ncRNAs, microRNAs (miRNAs) have emerged as an
important class of post-transcriptional regulators of gene
expression in virtually all fundamental cellular processes [9].
MiRNAs are transcribed within the nucleus and are then
extensively processed and matured in the cytosol as ,22-bp
double-stranded RNA. Mature miRNAs associate with Argo-
naute (AGO) proteins to form the core of a ribonucleoprotein
complex named RNA-induced silcencing complex (RISC), which
exerts RNA interference (RNAi) [10,11]. RNAi occurs upon
pairing one of the two miRNA strands, embedded in an AGO
protein, with target sites in an mRNA, thereby affecting the
stability/translation of this mRNA [11]. In mammals, there are
four AGO proteins, AGO1 through AGO4, which were all
shown to function in translational repression [12], but only
AGO2 can catalyze the cleavage of the targeted transcript
[13,14]. Furthermore, knockdown and knockout of AGO2,
respectively in human cells and in mice, suggest that the protein
may have specific functions that may not be complemented by
the other AGOs [13,15].
Initially, mature miRNAs and AGO2 were believed to
accumulate and function exclusively in the cytosol and/or into
unstructured cytosolic foci, such as P-bodies and stress granules
[16,17]. However, mounting evidence suggests that they can also
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e20746localize to and, possibly, function within different cellular
compartments. So far, in human, miRNAs and AGO2 have been
found to localize to the nucleus [18,19,20] and to multivesicular
bodies [21,22]. Recently, miRNAs were also identified in
mitochondria purified from rat liver [23]. Interestingly, another
possible link between mitochondria and RNAi came from the co-
immunoprecipitation of human AGO2 with mitochondrial
tRNA
Met [24].
In mitochondria, post-transcriptional regulation via miRNAs
would provide a sensitive and rapid mechanism by which to adjust
the expression of the mitochondrial genome in relation to the
conditions and metabolic demands of the cell. Therefore, our aim
was to investigate the possible link between miRNAs and
mitochondria in human cells. Our study provides the first
comprehensive view of the localization of RNAi components to
human mitochondria.
Results
Investigating AGO2 at the mitochondria
We first addressed the possibility that endogenous AGO2 could
localize to mitochondria. To isolate highly-purified mitochondria,
we performed cell fractionation combined with subsequent
immunoisolation of mitochondria. This isolation procedure
adapted from Hornig-Do et al. [25] was checked for efficiency
by measuring the activity of mitochondrial and cytosolic marker
enzymes (Supporting Information S1). Mitochondrial fraction was
analyzed for its purity by immunoblot as assessed by the
mitochondrial marker ATP synthase subunit a 1 (ATP5A1) and
the nuclear/cytosolic marker cyclin-dependent kinase 2 (CDK2),
which indicated the lack of nuclear and cytosolic contaminants
reproducibly (Figure 1A). To study the localization of endogenous
AGO2, we chose the same polyclonal antibody as that used in the
founding studies of AGO2 localization [16,26,27]. By immuno-
blotting, we detected AGO2 as a band of ,102 kDa in HeLa
mitochondrial proteins as well as in the total protein extract from
the same cells (Figure 1B). Assessment of actin as a cytosolic
marker further validated the lack of cytosolic contaminants
(Figure 1B). To further ascertain AGO2 at mitochondria, we
extracted the crude membrane pellet and the soluble protein
fraction from mitochondria isolated from a U2OS cell line.
Mitochondria were incubated in hypo-osmotic buffer alone or
supplemented with either 1 M NaCl or 0.1 M Na2CO3,p H1 1
prior and after fragilization. Efficacy of treatments was ensured by
immunoblotting detection of the following proteins: voltage-
dependent anion channel 1 (VDAC1), cytochrome c (CYCS)
and NADH dehydrogenase (ubiquinone) 1 a subcomplex 9
(NDUFA9), which all showed patterns consistent with the known
location of those markers, respectively as a mitochondrial
membrane marker, an intermembrane marker and a mitochon-
drial membrane marker (Figure 1C). As shown in Figure 1C,
AGO2 was detected in the mitochondrial membrane fraction and
to a lesser extent in the soluble fraction, suggesting its preferential
association to mitochondrial membranes.
Mitochondrial localization of AGO2 was further assessed by
immunofluorescence confocal microscopy. Immunostaining of
AGO2 showed a consistent punctuated cytoplasmic and nuclear
pattern. Overlay of AGO2 immunostaining with mitochondrial
staining indicated a partial co-localization as assessed by two
distinct antibodies (Figure 2). Correlation between the intensities
of green (AGO2) and red (mitochondria) in dual-channel images
was studied using the Pearson’s correlation coefficient (rp) in
three different human cell lines, whether tumoral or transformed
i.e HeLa, U2OS and HEK293 cells (Figure 2). Average values of
rp$0.5 indicated a significant correlation of green and red
pixels, which was consistent in all cell types. Evidence of co-
localization was improved using an additional parameter, which
is the Van Steensel’s cross-correlation function (CCF; [28]).
Plotted CCF revealed curves with a bell-like shape further
indicating that AGO2 and mitochondria were positively
correlated (Figure 2).
Interestingly, the use of four prediction programs to identify
subcellular protein localization (i.e TargetP [29], MitoProt II [30],
Predotar [31] and ESLPred [32]) all consistently predicted a
mitochondrial localization of AGO2, specifically when assessing
the CRA-b isoform (Table S1). For that isoform, TargetP and
MITOProt II delineated an N-terminal region of 9–24 amino
acids that could support a mitochondrial targeting sequence
(Table S1).
To assess the possibility of AGO2 to function at the
mitochondria, we then examined whether AGO2 could interact
with the mitochondrial transcript cytochrome c oxidase III (COX3)
as previously found in HEK293 cells [33]. By co-immunoprecip-
itating endogenous AGO2 with the associated RNAs in HeLa cell
extracts and subsequent RT-PCR, we consistently identified COX3
as reproducibly associated, in comparison to a mitochondrial
transcript cytochrome b (cyt b) and a cytosolic transcript
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) that were
not associated (Figure 3). Those co-immunoprecipitation results
were performed along the control immunoprecipitation of a
transcriptional factor SLUG, which as expected did not lead to the
identification of any targets. Collectively, our data support the
novel localization and functioning of AGO2 at the human
mitochondria, a finding that prompted us to search for
mitochondrial miRNAs.
Isolation of mitochondrial and cytosolic RNAs
We reasoned that differential identification of miRNAs in
subcellular compartments from the same cells would provide the
most reliable and effective method to investigate localization of
miRNAs to mitochondria. Our experimental design enabled us to
isolate mitochondria and cytosol fractions from the same cells and
to profile differentially expressed miRNAs in each fraction using
the miRXplore
TM microarrays (Figure 4A). Total RNA was
isolated respectively from mitochondrial and cytosolic fractions.
Each RNA fraction was examined for its integrity, quality and
purity through the Agilent 2100 Bioanalyzer. Electrophoretic gel
images were observed for mitochondrial and cytosolic RNA
fractions (Figure 4B). Consistently with the electrophoregrams,
the 28S rRNA and 18S rRNA, which are located exclusively in
the cytoplasm, were not observed in the mitochondrial RNA
fraction indicating that mitochondrial and cytoplasmic RNA
fractions were distinct. We further applied the RNA Integrity
Number (RIN) algorithm to each sample to assign an integrity
value [34]. Mean RIN values were respectively of 2.8 and 8.3 for
the mitochondrial and cytosolic fractions. The cytosolic value was
indicative of RNA of high quality. Since no standard exists as to
the mitochondrial fraction, which consists of a distinct RNA
population, we considered a value smaller than 6 as an indication
of the depletion of cytosolic RNAs that we further ascertained by
the depletion of cytosolic 18S and 28S rRNAs from mitochon-
drial RNA in the Bioanalyzer run. Finally, we assessed the purity
of mitochondrial and cytosolic RNA fractions by reverse
transcription-polymerase chain reaction (RT-PCR). 16S rRNA,
which was chosen as a mitochondrial marker and thereby as a
positive control for mitochondrial RNA, was enriched in the
mitochondrial RNA fraction whereas it was depleted from the
cytosolic RNA (Figure 4C). In contrast, GAPDH, an unambiguous
Mitochondrial miRNAs (mitomiRs) and AGO2
PLoS ONE | www.plosone.org 2 June 2011 | Volume 6 | Issue 6 | e20746Figure 1. Novel localization of Argonaute 2 (AGO2) to human mitochondria. A. Purity assessment of mitochondrial fraction. Cyclin-
dependent kinase 2 (CDK2) was assessed in the mitochondrial fraction by immunoblot analyses to check for nuclear and cytoplasmic contaminants
relatively to mitochondrial protein ATP synthase subunit a (ATP5A1). The density of bands was measured using the ImageJ software and is
represented as a relative intensity. Values are means6SD of three independent experiments. B. Western blot analysis of AGO2 in subcellular
mitochondrial fraction from HeLa cells. AGO2 protein was detected using a rabbit polyclonal antibody anti-AGO2 in mitochondrial protein fraction
(Mito) and total protein extracts (Lysate) from HeLa cells. ATP5A1 was used as a mitochondrial marker, actin as a cytosolic marker, and CDK2 as a
nuclear/cytosolic marker. Representative image is shown of three independent experiments. C. Western blot analysis of AGO2 at mitochondrial
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fraction (Figure 4C). Altogether, these data indicated that no
cytosolic contaminants could be detected in mitochondrial RNA,
while faint signals of mitochondrial RNA were detected in the
cytosol. These results are consistent with a high level of purity in
either fraction.
Differential expression of mature miRNAs in the
mitochondria and the cytosol
We profiled miRNAs at the genome-wide scale in the
mitochondrial and cytosolic RNA fractions purified from HeLa
cells (Figure 4A). Mitochondrial and cytosolic RNA were labeled
using the fluorescent dyes Hy5 and Hy3, respectively, and
Figure 2. AGO2 protein co-localizes with mitochondria in human cell lines. Cells were fixed and endogenous AGO2 detected with two
distinct antibodies (rabbit polyclonal anti-AGO2, clone 7C6, A, D; mouse-monoclonal anti-AGO2, clone 4G8, B, C) and visualized by indirect
immunofluorescence. Mitochondria were either stained with Mitotracker Red CMXRos (E–G) or immunostained with anti-ATP5A1 (H). Overlay images
show colocalization of AGO2 and mitochondria (I–N). A sample of 21 cells was examined for dual channel co-localization for each cell type. Co-
localization was also confirmed by Pearson’s correlation coefficient (rp), whose value is indicated at the bottom of each overlay image. Cross-
correlation functions (CCFs) were calculated for each co-localization. Representative plots obtained from the analysis of a single microscopic field are
shown (O–R). Maximum CCF and pixel shift (dx) values are respectively indicated at the top and the bottom of each plot. Scale bar, 10 mm.
doi:10.1371/journal.pone.0020746.g002
membranous and soluble fraction from U2OS cells. Mitochondria were suspended either in isotonic mitochondrial buffer (MB) or in hypo-osmotic
mitochondrial buffer (MB/10) alone or supplemented either with NaCl 1 M or Na2CO3 0.1 M, and fragilized by freeze-thaw cycles and sonication when
indicated. All samples were centrifuged (150,0006g) to separate the membrane pellet (p) from the soluble protein supernatants (s). 15 mg of protein
extracts of each sample were subjected to Western Blot. The following proteins were immunodecorated on blots: voltage-dependent anion channel 1
(VDAC1) and NADH dehydrogenase (ubiquinone) 1 a subcomplex 9 (NDUFA9) as markers of mitochondrial membranes and cytochrome c (CYCS), as a
intermembrane marker. Immunodetection of AGO2 is shown as the lower panel.
doi:10.1371/journal.pone.0020746.g001
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showing significant hybridization signals were analyzed for their
enrichment either in the mitochondrial or the cytosolic RNA
fractions by determining the Hy5/Hy3 ratio values. Using a cutoff
fold of enrichment of 1.5, we identified a subset of 57 miRNAs
differentially expressed in the mitochondrial and cytosolic RNA
fractions (Figure 5A). Two subgroups were clearly identified
suggesting that a specific population of miRNAs was likely
compartmentalized in mitochondria. While 44 miRNAs showed
a greater enrichment in the cytosolic Hy3-labeled RNA fraction,
13 miRNAs were significantly and reproducibly enriched in the
mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-
fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-
miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-
miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-
1978 and hsa-miR-1201 (Figure 5A). In parallel, microarray
experiments were repeated thrice with RNase A-treated mito-
chondria, giving a consistent signature of the same mitochondrial-
enriched miRNAs (Figure S1). This latter result emphasized the
actual localization of those miRNAs within the mitochondria. The
data are accessible through GEO Series (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE24761).
Microarray data was independently verified by RT-PCR
analysis assessing hsa-miR-494, hsa-miR-1275 and hsa-miR-
1974. For each we assessed the differential expression in HeLa
mitochondria relative to the mitochondrial control, 16S rRNA
(Figure 5B). All miRNAs were significantly enriched in mitochon-
dria as compared to the cytosol (p,0.03). Finally, we further
validated our results through a systematic comparison with
previously released miRNA expression data in HeLa cells, using
total RNA [35,36] (Table S2). We observed that the vast majority
of cytosolic-enriched miRNAs (84%) were reproducibly identified
in previous HeLa expression data while most of the mitochondrial-
enriched miRNAs (69%) were absent as expected from their
dilution in total RNA (Figure S2). Thus, our findings were
consistent with a signature of 13 miRNAs significantly enriched in
the mitochondrial RNA fraction. Notably, three of those miRNAs,
namely hsa-mir-1974, hsa-mir-1977 and hsa-mir-1978 are non-
canonical miRNAs for they map to the mitochondrial genome,
and they map to tRNA and rRNA genes. However, their size,
which ranges from 21–23 nucleotides is similar to miRNAs. The
identification of several small RNA similar in size to miRNAs that
are derived from abundant non-coding RNAs [37,38] prompted
us to consider hsa-mir-1974, hsa-mir-1977 and hsa-mir-1978 as
potential components of RNAi at mitochondria. For simplicity, we
termed those three miRNA-like RNAs and the other detected
miRNAs, ‘mitomiRs’ in reference to their preferential localization
in HeLa mitochondria. We examined the conservation of all
mitomiRs by systematic BLAST of their sequences against those
from metazoan species. To our surprise, despite the fact that most
miRNAs are conserved accross metazoans [39], only two of the 13
mitomiRs, i.e hsa-miR-494 and hsa-miR-328, were highly
conserved while the others were either human-specific or only
conserved in primates (Table 1).
MitomiRs targeting analyses
We systematically assessed the computational targeting of all
mitomiRs. To obtain unbiased predictions, we analyzed the
targeting of the 13 mitomiRs in parallel to a control sample of 13
cytosolic-enriched miRNAs. For each miRNA, targets were
predicted (Table S3) and then analyzed for enrichment in nuclear
genes coding for proteins known as mitochondrial [40]. Mean
percentage of these genes within the mitomiR target set reached
1763 versus 17.662.8 in the control set. This difference was not
statistically significant (Table S4 and Figure S3). Thus, mitomiRs
appeared to lack any preferential predicted targeting of the
mitochondrial genes encoded by the nuclear genome.
We then questioned the functional relevance of those
mitomiRs. To this end, we used the ExParser algorithm with
the publicly available datasets to retrieve the mRNA genes
experimentally classified as targets of miRNAs and/or as co-
regulated in their expression with mitomiRs [36]. While lack of
available experimental data precluded systematic questioning, we
were able to analyze the target and/or co-regulated mRNAs for
hsa-miR-328, hsa-miR-494, hsa-miR-513 and hsa-miR-638
(Table S5). For each mitomiR, the compiled mRNAs were then
assessed for their biological significance using a systems biology
pathway analysis tool [41]. We found that all four mitomiRs were
significantly involved in mitochondrial homeostasis, e.g hsa-mir-
494 and hsa-mir-513 are both involved in ATP synthesis coupled
electron transport (Figure 6). One common feature of their
involvement pointed out their role in translation initiation and in
cell cycle (Figure S4). In particular, the most significant result of
hsa-mir-494 is in mitochondrial translation (p-value=3.5610
27)
(Figure S4).
Subsequently, we hypothesized that mitomiRs may directly
affect the mitochondrial genome. To scan the mitochondrial
genome for potential miRNA target sites, we used four
independent and complementary algorithms RNA22, RegRNA,
miRWalk and Target Scan (described in the Methods). Ten of
the 13 mitomiRs were predicted to target a total of 120 target
sites along the mtDNA sequence. We found target sites mapping
each mtDNA-encoded protein genes, except for ND4L (Table 2).
Merging the targeting analyses from the independent searches
highlighted that the most frequent target sites were located at
ND1, ND4, ND5, ND6, COX1 and COX2 (Table 2). Interestingly,
the first four genes encode the components of the first complex of
the respiratory chain. However, it should be emphasized that the
actual location of targets does not necessarily concern the
Figure 3. Co-immunoprecipitation of AGO2 and mitochondrial
transcripts. Either AGO2, or SLUG, which serves as a negative control
were co-immunoprecipitated with associated mRNAs in HeLa protein
extracts. Coimmunoprecipitated RNA was extracted with Trizol and
subjected to RT-PCR amplification with the indicated primers:
cytochrome c oxidase III (COX3), cytochrome b (cyt b) and glyceralde-
hyde-3-phosphate dehydrogenase (GAPDH). Results are indicative of
three independent experiments.
doi:10.1371/journal.pone.0020746.g003
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drial genome (reviewed in [42]). To gain insight into the
biological relevance of those predictions, we performed the same
analysis with the control set of cytosol-enriched miRNAs, and
found a preferential targeting of mitomiRs versus cytosolic
miRNAs (Table S6).
Genomics and intrinsic features of the mitomiRs
To gain insights into the molecular basis underlying the
mitochondrial localization of miRNAs, we first questioned their
genomics. Since it is widely accepted that most miRNAs share
regulatory elements with their genomic environment, and when
intragenic are typically co-processed from the host gene mRNAs,
we inferred that the genomic location of mitomiRs might be
informative [43]. Interestingly, the 13 mature mitomiRs appear to
be expressed from 15 miRNA genes (Table 3). Of those 15 genes,
9 were intragenic while 6 were intergenic (Table 3). We found that
genomic locations of the mitomiRs, besides hsa-miR-513a and
hsa-miR-1275 were all relevant to mitochondria. In particular, of
9 intragenic mitomiRs, 4 were hosted in mitochondrial genes
(Table 3). Strikingly, hsa-miR-1974, hsa-miR-1977 and hsa-miR-
1978 also exhibited a perfect match in the mitochondrial genome
Figure 4. Isolation of mitochondrial and cytosolic miRNA. A. Schematic workflow of the experimental design. B. Integrity, quality and purity
analyses of RNA fractions. Electrophoretic images of mitochondrial and cytosolic RNAs were retrieved from analysis using the Agilent 2100
Bioanalyzer. Bands corresponding to ribosomal RNAs (rRNAs) 16S, 12S, 28S and 18S are indicated when present. Representative image is shown of
three independent experiments. C. Purity assessment of mitochondrial RNA fraction. 16S rRNA and GAPDH were amplified by RT-PCR in each fraction
as shown by electrophoretic image. GAPDH was assessed in the mitochondrial fraction to check for cytoplasmic contaminant relatively to
mitochondrial 16S ribosomal RNA. Representative image is shown of three independent experiments. The density of bands was measured using the
ImageJ software and is represented as a relative intensity. Values are means6SD of three independent experiments.
doi:10.1371/journal.pone.0020746.g004
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stretch of the mitochondrial rRNA sequence RNR1, respectively.
Thus, in addition to the nuclear transcription that can be assumed
from the detection of hsa-miR-1974 in the cytosol (Figure 5B), it
will remain to be ascertained whether the transcription of those 3
mitomiRs could also occur from the mitochondrial genome.
Figure 5. Evidence for a mitochondrial miRNA signature in HeLa cells. A. Heatmap showing the 57 miRNAs differentially expressed in HeLa
cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and
reproducibly revealed 13 miRNAs enriched in mitochondrial RNA. Log2 Hy5/Hy3 ratios are color scaled in gradient from green (low levels) to red (high
levels) as indicated by the scale bar. B. Validation of microarray data by RT-PCR. Five genes (hsa-miR-494, hsa-miR-1974, hsa-miR-1275, 16S rRNA and
GAPDH) were selected for microarray data validation of differential expression in either subcellular compartment. 16S rRNA was used as a positive
mitochondrial control, while GAPDH as a negative mitochondrial control. Quantitative analysis of band intensities are shown for three independent
RT-PCR experiments and indicated as arbitrary units (a.u.) in either mitochondria (grey) or cytosol (black). Error bars represent the standard erroro f
the mean. Asteriscs indicate statistically significant differences as compared to the cytosol (hsa-miR-494, p-value=3.32610
25; hsa-miR-1974, p-
value=0.02; hsa-miR-1275, p-value=6610
24; 16S rRNA, p-value=0.03).
doi:10.1371/journal.pone.0020746.g005
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mitomiRs. We assessed their lengths and thermodynamic features
in comparison to the same control sample of 13 cytosolic-
enriched miRNAs. Unequivocally, the control sample shared all
expected features of miRNAs, in particular an average length of
22-nt for the mature and of 82-nt for the pre-miRNA sequence
(Figure 7A). In contrast, the length of the mature mitomiRs
varied substantially. Three mitomiRs were smaller than 19 nt
(Table S7). In fact, the length distribution of the mature
mitomiRs was significantly different from the control (p,0.005)
but did not correlate with a difference at the pre-miRNA
sequence level, which remained comparable (p=0.2) (Figure 7A–
B). Thus, we assessed the thermodynamic stability of the
secondary structures of the mitomiRs by calculating their
minimum folding energy (MFE). MFE displayed a significantly
different distribution than the control group (p=0.01) (Figure 7C,
Table S7, and Table S8). Because MFE is strongly correlated
with the length of the sequence, we also calculated the adjusted
MFE (AMFE) (Table S7). Again, the distribution of AMFE values
was significantly different from that of the control miRNAs
(p,0.05), which revealed that mitochondrial-enriched miRNAs
shared specific distinctive features as a group (Figure 7D, Table
S7 and Table S8).
Altogether, our findings illustrate a species-specific signature of
mitochondrial miRNAs of unusual sizing that exhibit unique
thermodynamic features. These results suggest a set of emerging
features of structural properties that should help in the
identification of other mitomiRs.
Discussion
Little is known about the crosstalk between the nucleus
and mitochondria, despite the fact that this communication has
great relevance for understanding integrative cellular signaling
pathways. In this report, we have used complementary
approaches to provide evidence that all components of RNA
interference are present at the mitochondria in human cells
(Figure 8).
We identified a set of 13 miRNAs significantly enriched in
mitochondria purified from HeLa cells that we referred to as
mitomiRs. We believe that our experimental design, focusing on
the differential expression of miRNAs in subcellular fractions
isolated from the same cells, favored the identification of a
specific signature of miRNAs in mitochondria. Recently,
comparable approaches were successfully used for the identifica-
tion of nuclear and nucleolar small RNAs [19,44]. In our
methodology, the choice of immunoisolating mitochondria after
differential centrifugation gave us the additional opportunity to
wash the organelles in stringent conditions, leading to highly
purified mitochondrial fractions. Our findings not only identify a
novel set of mitochondrial miRNAs in humans, but also confirm
the previous finding of enrichment of miR-494 in rat liver
mitochondria [23]. Our analysis of genes hsa-mir-494 function-
ally-related revealed its involvement in regulating translation in
mitochondria. Thus beyond a role in the cytosol, hsa-miR-494
likely displays conserved functions relevant to its mitochondrial
localization.
Our study further introduces the idea that a nuclear
outsourcing of miRNAs to mitochondria is conserved in
mammals. Indeed, extensive mapping of our mitomiRs, as well
as the mitochondrial miRNAs identified in rat liver [23] (data
not shown) demonstrated that they mostly originated from the
nucleus. Noteworthy, hsa-miR-1974, hsa-miR-1977 and hsa-
miR-1978 are considered non-canonical miRNAs because they
map to mitochondrial tRNA and rRNA genes. At this stage, our
data on other mitomiRs and AGO2 at the mitochondria prompt
to gain more insights into the accuracy of those three miRNA-
like RNA production, whether from nuclear or mitochondrial
genome, and from specific enzymatic cleavage or from random
degradation. As for hsa-miR-1201, which is also questioned
as a genuine miRNA due to the overlap with an annotated
small nucleolar RNA (SNORD126), we considered that its
binding to both AGO2 and mRNAs [45] sufficiently argued for
its possible functioning as a mitomiR. Although the mechanism
of miRNA localization to mitochondria is unclear at this stage,
our analysis suggests that their hosting in specific genomic
Table 1. Cross-species conservation of pre-miRNA sequences in metazoans.
miRNA identifier Species (taxonomic orders) Conservation score*
hsa-miR-1973 Hsa (Primates) 0
hsa-miR-1275 Hsa, Ptr, Ppy (Primates) 1
hsa-miR-494 Hsa, Ptr, Ppy, Mml, (Primates), Mmu, Rno (Glires), Cfa (Carnivora), Eca, Bta (Perissodactyla), Ssc
(Cetertiodactyla)
2
hsa-miR-513a Hsa, Ptr, Ppy, Mml, Age, Ssy, Pbi (Primates) 1
hsa-miR-1246 Hsa, Ptr, Ppy (Primates) 1
hsa-miR-328 Hsa, Ptr, Ppy, (Primates), Mmu, Rno (Glires), Cfa (Carnivora), Eca, Bta (Perissodactyla), Ssc
(Cetertiodactyla)
2
hsa-miR-1908 Hsa, Ppy (Primates) 1
hsa-miR-1972 Hsa (Primates) 0
hsa-miR-1974 Hsa (Primates) 0
hsa-miR-1977 Hsa (Primates) 0
hsa-miR-638 Hsa, Ppy, Mml (Primates) 1
hsa-miR-1978 Hsa (Primates) 0
hsa-miR-1201 Hsa, Ptr, Ppy (Primates) 1
*Conservation score was assigned as follows: 0 for miRNA sequences that were human specific; 1 for miRNAs sequences conserved in primates; 2 for miRNA sequences
conserved in more than 2 orders.
doi:10.1371/journal.pone.0020746.t001
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play a significant role in the specificity of this subcellular
localization. Our observation also indicates that most human
mitomiRs are not conserved beyond primates, which may
suggest a species-specific targeting of miRNAs to human
mitochondria. We propose that this biased lack of conservation
throughout species likely relates to the peculiar evolutionary
pressure that concerns mitochondrial genomes [46,47]. We
speculate that further investigation specifically on hsa-miR-1974,
hsa-miR-1977 and hsa-miR-1978, which are human-specific
only may greatly serve our understanding into both the origin
and evolution of miRNAs.
The actual mitochondrial localization of some miRNAs implies
that small RNA-mediated processes may regulate mitochondrial
biogenesis and function. This hypothesis involving an additional
level of nuclear control of mitochondria is emphasized by our
finding that AGO2 localizes to mitochondria, and that we and,
others, identified its binding to the mitochondrial transcripts
COX3 and tRNA
Met [24,33]. AGO2 may be considered as a
versatile protein, localized to several sites within the cell,
including unstructured foci and vesicles [16,17,21,48], the Golgi
apparatus and the endoplasmic reticulum [26] but also the
nucleus [20]. Yet, it is not clear which of these cellular structures
are necessary for AGO2 functions [49]. Depending on its
localization, different functions have already been ascribed to
AGO2, such as post-transcriptional gene silencing or reversible
translational regulation in P-bodies [50] and stress granules [16],
and transcriptional regulation in the nucleus [51]. Given the
unique features of mitochondria in terms of genomic organization
and regulation [52], it is difficult at this stage to predict role of
AGO2 at the mitochondria. Here, our prediction that the
isoforms of AGO2 may be differently regulated in respect to their
localization to mitochondria adds an additional layer of
complexity. Which of the AGO2 isoforms actually localizes to
Figure 6. Ontology enrichment analysis for target genes of hsa-miR-328, hsa-miR-494, hsa-miR-513 and hsa-miR-638. The ExParser
algorithm was used to compile datasets of genes whose expression patterns were comparable and statistically correlated to the expression patterns
of the four mitomiRs. The datasets were uploaded into MetaCore
TM and analyzed in respect to the Gene Ontology Process. Ten most significantly
enriched processes for the genes targeted by hsa-miR-328, hsa-miR-494, hsa-miR-513 and hsa-miR-638 were scored and ranked in respect to the
obtained p-values. Bars represent significance as 2log(p-value) for hypergeometric distribution. Ontology enrichments were all filtered to allow no
more than 5% false discovery rate.
doi:10.1371/journal.pone.0020746.g006
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underlying mechanism of such mitochondrial targeting remain
to be explored in future studies. In this respect, interesting
insights come from the proteomic studies of AGO2 partners,
which identified mitochondrial proteins mostly from the inner
membrane, including many ATP/ADP translocases, carriers and
ribosomal proteins as binding partners [53]. These data,
altogether with the recent finding that AGO2 also associates
with HSP90 [54] provide interesting rationales as to a possible
mechanism for a mitochondrial import of AGO2. Furthermore,
our computational identification of miRNA targets in the
mitochondrial genome actually provided the first step towards
elucidating the functions of AGO2 at the mitochondria.
However, technical limitations of directly transfecting mitochon-
dria in vivo will make it challenging to test the classical approaches
to characterize the regulatory role of mitomiRs and AGO2 at the
mitochondria.
To conclude, the nuclear outsourcing of miRNAs and AGO2 at
the mitochondria is likely an additional mechanism mediating the
crosstalk between the nucleus and mitochondria (Figure 8). Based
on our study, consideration of the mitomiRs as a new species for
mitochondrial regulatory RNAs may lead to a deeper under-
standing of signaling pathways that require nuclear-mitochondrial
cooperation. Elucidating the preferential distribution of miRNAs
to mitochondria should then provide a first framework to further
investigate their organelle-specific functions and to unravel their
potential in devising new therapeutic strategies.
Materials and Methods
Genomic and protein sequences
NCBI entries of the protein sequences of human AGO2 (also
referred to as EIF2C2) were systematically retrieved (Gene
Identity: 6468775, 14043279, 62913977, 119612613, 29171734,
257467482, 133777965 and 119612614). The dataset for miRNA
sequences were downloaded from the Sanger miRBase database
Release 13.0 [55]. The studied mitochondrial genomic DNA
(mtDNA) sequence was retrieved from NCBI (NC_012920).
Genomic and protein bioinformatic analyses
Genomic and chromosomal locations were analyzed through
the Ensembl and UCSC genome browsers (release 59), and our in-
house developed bioinformatic tool to question miRNAs and
genetic loci/diseases (http://www.mirifix.com, Henrion-Caude
personal communication). Mapping of the mature miRNA
sequences on genomic nuclear and mitochondrial DNA was
performed using BLAT [56]. Conservation of each miRNAs was
assessed through BLASTN with default parameter values [55].
Molecular weight of each AGO2 entry was calculated using the
ProtParam tool [57] to identify the adequate protein sequences to
be further analyzed. Predictions of subcellular localization were
done using the following three network-based approaches, namely
TargetP 1.1 [29], MitoPROT II v. 1.101 [30], PREDOTAR 1.03
[31], and a support vector machine-based method integrative of
multiple features of the protein: physicochemical properties, amino
Table 2. List of mitomiR-predicted target sites in the mitochondrial genome.
Computational tools
RNA22 RegRNA MiRWalk Target Scan
mitomiR
Gene hosting
miRNA target sites
Gene hosting
miRNA target sites
Gene hosting
miRNA target sites p-value (,0.05)
Gene hosting
miRNA target sites
hsa-miR-1973 - - - -
hsa-miR-1275 ND5, CYTB, COX2, ATP8,
ND2, COX1, D-loop
ND4, ND5, D-loop ND6 0.008 COX2, ND4, ND6
hsa-miR-494 - - - -
hsa-miR-513a-5p - - - -
hsa-miR-1246 ND5, COX1 - COX1 0.002 ND5, COX1
hsa-miR-328-5p RNR1 - - -
hsa-miR-1908 ND6, CYTB, ND4, COX2, ND1 COX1, RNR2, D-loop,
ND3, TRNN, ND5,
ND4, ATP8/ATP6
COX1 0.02 D-loop, RNR2, COX1, ND3
hsa-miR-1972 COX1, COX3, L-strand
replication origin region
COX1 - COX1
hsa-miR-1977 ND4, TRNN, TRNP, ND2,
RNR2, ND5, TRNL2
TRNN - TRNN, COX1, ND5, CYTB
hsa-miR-638 ATP6, TRNP, TRNY, D-loop,
COX1, ND5, ND2, CYTB,
ATP8, ND1, ND3, RNR2
COX2 COX2 0.01 COX2
hsa-miR-1974 ND6/TRNE, ND5, CYTB, ND4,
ATP6, TRNS2/TRNL, ND1
ND6/TRNE, ND1 - Dloop, ND1, ND2, ND5, TRNE
hsa-miR-1978 ND1, COX2, COX1 - - Dloop, RNR2, ND2, COX1,
COX2
hsa-miR-1201 TRNF, COX2, ATP6 - - -
– indicates the lack of targeting sites predicted at the level of mitochondrial genome.
The mitochondrial genes indicated in bold present overlapping target sites between RegRNA and RNA22 or RegRNA and miRWalk. The (promoter or mRNA sequence) is
calculated by. P-values were calculated using Poisson distribution as a probability distribution of random matches of a subsequence (miRNA 59 end sequence) in the
given sequence calculated. Low probability implies a significant hit (p,0.05).
doi:10.1371/journal.pone.0020746.t002
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BLAST information [32].
Cell culture
HeLa cells were grown in DMEM medium completed with
10% fetal bovine serum and 100 U/ml penicillin-streptomycin.
Similar conditions of culture were used for HEK293 and U2OS
cells. Cell lines were purchased from ATCC (ATCC, Manassas,
VA, USA). For cell fractionation, HeLa cells were allowed to reach
80–100% confluence. For immunocytochemistry, cells were
allowed to reach 60% on glass coverslips.
Isolation of mitochondria and cytosol
We isolated mitochondria with the Mitochondria Isolation kit
(Miltenyi Biotec, Bergisch Gladbach, Germany) as described [25],
with several modifications that allowed the isolation of the cytosol
from the same cells. Briefly, HeLa cells were harvested at 80–
100% confluency and washed twice with phosphate-buffered
saline (PBS). Cells (3610
7) were lysed in 1 ml of Lysis Buffer from
the kit, complemented with Complete Protease Inhibitor Cocktail
Tablets (Roche, Mannheim, Germany). Then, the lysate was
divided into two aliquots. In order to isolate mitochondria, the first
aliquot was homogenized by shearing through a 29G needle 55
times. To magnetically label mitochondria, the cell lysate was
incubated with 50 ml of monoclonal anti-TOM22-conjugated
microBeads for 1 hour at 4uC. Then, the suspension of labeled
mitochondria was loaded onto a pre-equilibrated MACS Column
(Miltenyi Biotec, Bergisch Gladbach, Germany), previously placed
in the magnetic field of a MACS Separator (Miltenyi Biotec,Ber-
gisch Gladbach, Germany). Due to the strong magnetic field
generated by the MACS Separator, labeled-mitochondria were
retained into the column. The column was washed three times
with 3 ml of PEB buffer (PBS pH 7.2, 2 mM EDTA and 0.5%
BSA). Subsequently, the column was removed from the magnetic
field and the retained mitochondria were eluted in 1.5 ml of PEB
buffer. After elution, mitochondria were suspended again in 9 ml
of PEB buffer, applied to a fresh column, washed and eluted for a
second time. When noted, mitochondria were treated with RNase
Table 3. Genomic and chromosomal locations of mitomiRs.
miRNA (miRBase v.13) Genomic location (hg19)
Chromosomal
location (hg19) Host gene
Genomic link to mitochondria -
Evidence
hsa-miR-1973 Chr4: 117220905–117220924 (+) 4q26 Intergenic Embedded in a region of
mitochondrial pseudogenes.
hsa-miR-1275 Chr6: 33967794–33967810 (2) 6p21.31 Intergenic None.
hsa-miR-494 Chr14: 101496018–101496039 (+) 14q32.31 Intergenic Embedded in a syntenic conserved
region of mitochondrial carrier
proteins [75].
hsa-miR-513a (1) Chr X: 146295056–146295073 (2) Xq27.3 Intergenic Localization (1) and (2): none.
(2) Chr X: 146307418– 146307435 (2)
hsa-miR-1246 Chr2: 177465752–177465770 (2) 2q31.1 Intergenic Embedded in a region of
mitochondrial genes – Locus involved
in mitochondrial disorders (EOMFC).
hsa-miR-328 Chr16: 67236230–67236251 (2) 16q22.1 Intragenic Locus involved in mitochondrial
disorders (CDG2H, MDDS2).
hsa-miR-1908 Chr11: 61582681–61582701 (2) 11q12.2 Intragenic Hosted in FADS1 intron
(mitochondrial localization [76]).
hsa-miR-1972 (1) Chr16: 151041224–15104246 (2) (1) 16q13.11 Intragenic Localization (1): None.
(2) Chr16: 70064295–70064317 (+) (2) 16q22.1 Localization (2): Locus involved in
mitochondrial disorder (CDG2H,
MDDS2).
hsa-miR-1974 Chr5: 93905172–93905194 (2) 5q15 Intragenic Hosted in mitochondrial pseudogene
(AC093311.4) and embedded in a
region of mitochondrial pseudogenes.
Likely transcription from the
mitochondrial genome (TRNE, M:
14675–14697 (2)).
hsa-miR-1977 Chr1: 566242–566263 (2) 1p36.33 Intragenic Hosted in mitochondrial pseudogene
(AC114498.7) and embedded in a
region of mitochondrial pseudogenes.
Likely transcription from the
mitochondrial genome (TRNN,
M:5693–5714 (2)).
hsa-miR-638 Chr19: 10829095–10829119 (+) 19p13.2 Intragenic Hosted in DNM2 (mitochondrial
localization [40]).
hsa-miR-1978 Chr2: 149639365–149639385 (2) 2q23.1 Intragenic Possible transcription from the
mitochondrial genome (RNR1, M: 654–
674 (+)).
hsa-miR-1201 Chr14: 19864456–19864479 (2) 14q11.2 Intragenic Locus involved in mitochondrial
disorders (PCK2D).
doi:10.1371/journal.pone.0020746.t003
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shown in blue for the mitomiRs and red for the control miRNAs. Length of mature miRNAs (A) and of pre-miRNAs (B), and values of minimal folding
free energy (MFE) (C) and adjusted MFE (AMFE) (D) are plotted for each miRNA from the 2 subgroups. Average values are shown as bars in each
subgroup. Asterics indicate significant differences between mitomiRs versus control miRNAs (p-value,0.05). NS indicates not significant p-value.
doi:10.1371/journal.pone.0020746.g007
Figure 8. Integrative model for subcellular localization of RNAi components. Boxes represent the subcellular compartments. RNAi
components are encircled. Arrows indicate the molecular fluxes documented herein in regards to the mitochondrial miRNAs (mitomiRs), and
previously in P-bodies (PBs) [17], stress granules (SGs) [16,54], multivesicular bodies (MVBs) [21] and Golgi [26]. Depending on the localization,
different functions are ascribed to AGO2, such as post-transcriptional gene silencing or reversible translational regulation in P-bodies [50] and stress
granules [16], and transcriptional regulation in the nucleus [51]. In mitochondria, the presence of mitochondrial genome adds another possible layer
of regulation by AGO2.
doi:10.1371/journal.pone.0020746.g008
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buffer (0.25 M sucrose, 2 mM MgCl2, 10 mM Tris HCl pH 7.4)
and treated with 50 mg protease-free RNase A (USB-Amersham)
either for 15 min at room temperature as described in [58], or for
30 min at 4uC as described in [23] and washed twice in suspension
buffer. Mitochondrial pellet was recovered after centrifugation at
13,0006 g for 2 min at 4uC. Mitochondrial integrity was
monitored after resuspension of the mitochondrial pellet by
measuring citrate synthase activity, before and after membrane
disruption by adding Triton X-100, as previously described [59].
Mitochondrial fraction of U2OS was isolated using standard
method (protocol Mitosciences, adapted from [60]). Extraction of
mitochondrial soluble proteins from integral membrane proteins
was performed through sodium carbonate treatment as described
[61].
In order to isolate the cytosolic fraction, the second aliquot of
crude HeLa lysate was homogenized through a glass homogenizer
in homogenization buffer (210 mM manitol, 70 mM sucrose,
1 mM EDTA, 10 mM Hepes-NaOH, pH 7.5), as previously
described [62]. The homogenate was centrifuged at 2,0006g for
30 min at 4uC to remove nuclei and unbroken cells. The
supernatant was recovered and subsequently centrifuged at
13,0006 g for 10 min to give the cytosolic fraction, which was
subjected to RNA extraction.
Protein and RNA extraction
For total protein extraction, HeLa cells were lysed as previously
described [33]. Pelleted mitochondria were lysed as described
previously [63]. For RNA extraction, pelleted mitochondria and
cytosolic fractions were subjected to RNA isolation by Trizol and
Trizol LS (Life Technologies, Carlsbad, USA) extraction methods,
respectively, according to instructions of the manufacturer.
Microarray miRNA profiling
MicroRNA microarray analysis was performed by Miltenyi
Biotec Company (Milteny Biotec, Bergisch Gladbach, Germany).
Briefly, the concentration of mitochondrial and cytosolic RNAs
was measured by spectrophotometry at A260/280 and the quality
of the RNA sample was assessed using the Agilent 2100
Bioanalyzer (Agilent Technologies, Palo Alto, USA). 2 mgo f
respective mitochondrial and cytosolic RNA were each mixed with
2.5 fmol of miRControl 3, which comprises 18 RNA oligonucle-
otides, used as calibrators for normalization. Then mitochondrial
RNA was Hy5-labeled while cytosolic RNA was Hy3-labeled
using a commercial kit (miRCury
TM LNA microRNA Array
Power labeling kit, Exiqon, Copenhagen, Denmark). The
corresponding total RNA samples were hybridized overnight in
a dual colour approach to miRXplore
TM Microarrays using the a-
Hyb
TM Hybridization Station (Miltenyi Biotec, Bergisch Glad-
bach, Germany). The miRXplore
TM Microarray is composed of
6228 DNA oligonucleotides with a sequence being reverse
complement to the respective mature miRNA or control RNA,
representing a total of 1460 miRNA sequences and 97 controls
with all probes spotted in quadruplicates. The 1460 miRNA
sequences covered sequence verified miRNAs of the species
human (878) mouse (696) and rat (426) as well as viral miRNAs
(141) and further mammalian species (76) as deposited in the
miRBase sequence database version 13.0. Image capture of
microarrays was done with the Agilent’s Microarray Scanner
System (Agilent Technologies, Palo Alto, USA). Signal quantifi-
cation of the scanned microarrays was done using ImaGene
software Version 8.0 (BioDiscovery, Los Angeles, USA). The data
generated for each sample on the array were analyzed with
PIQOR Analyzer software. Local background was subtracted
from the signal to obtain the net signal intensity and the Hy5/Hy3
ratios. Subsequently, the mean of the ratios of 4 corresponding
spots representing the same miRNA was computed. The mean
ratios were normalised using the miRControl 3.
Primers, reverse transcription and PCR experiments
For miRNAs, primers were designed as the exact mature
miRNA sequences (as indicated at the Sanger miRBase database,
v13.0), in comparison to the 16S rRNA (59-TATACCCACACC-
CACCCAAG-39). Oligonucleotides for GAPDH were designed
through the Primer3 Tool [64] as follows: forward 59-CGAC-
CACTTTGTCAAGCTCA-39 and reverse 59-AGGGGTCTA-
CATGGCAACTG-39, and used at 60uC for annealing. Primer
sequences for COX3 and cyt b were designed as described [65],
respectively used at 48uC and 58uC for annealing. Each
oligonucleotide was applied at a final concentration of 0.4 mM.
Reverse-transcription of 1 mg of mitochondrial and cytosolic RNA
after treatment with the RQ1 RNase-free DNase I (Promega,
Madison, USA) was performed using the miScript Reverse
transcriptase kit (Qiagen, Weiden, Germany) according to
manufacturers’ instructions. PCR were performed in triplicate in
20 ml final volume. Specificity of each PCR products was ensured
by the results of melting curve analysis and agarose gel
electrophoresis. Separated products were quantitated by band
densities using the ImageJ software and normalized to ethidium
bromide staining.
Antibodies, immunoblotting and immunocytochemistry
The following primary antibodies were commercially pur-
chased: mouse monoclonal anti-ATP5A1, MS507, Mitosciences,
Eugene, USA, 1:1000 for immunoblotting and 1:750 for
immunofluorescence; mouse monoclonal anti-NDUFA9,
MS111, Mitosciences, Eugene, USA, 1:5000; mouse monoclonal
anti-VDAC1, MSA03, Mitosciences, Eugene, USA, 1:2500;
mouse monoclonal anti-CDK2, sc-6248, Santa Cruz Biotechnol-
ogy, Santa Cruz, USA, 1:1000; mouse monoclonal anti-actin,
VMA1501R, AbCys, Paris, France, 1:500; rabbit monoclonal
anti-cythocrome c, 1896-1, Epitomics, Burlingame, USA, 1:2000
and rabbit polyclonal anti-SLUG, sc-15391X, Santa Cruz
Biotechnology, Santa Cruz, USA, 1:250. Rabbit polyclonal
anti-AGO2 was kindly provided by Pr Tom Hobman (clones
7C6 and 7C3) and the antibody was used at a dilution of 1:1000
for immunoblotting and 1:250 for immunofluorescence and co-
immunoprecipitation. Mouse monoclonal anti-AGO2 was kindly
provided by Pr Haruhiko Siomi and Pr Mikiko C. Siomi (clone
4G8) and the antibody was used at a dilution of 1:50 for
immunofluorescence and at a dilution of 1:300 for Western blot.
Secondary antibodies HRP-conjugated anti-mouse and anti-
rabbit were purchased (GE Healthcare Bio-Sciences, Little
Chalfont, UK). Fluorescein isothiocyanate (FITC)- and tetra-
methylrhodamine isothiocyanate (TRITC)-labeled secondary
antibodies for immunofluorescence microscopy were from
Invitrogen (Life Technologies, Carlsbad, USA). Equal amounts
of protein (40 mg) were size-separated through a 3–8% sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (NuPage
Novex Mini gel; Life Technologies, Carlsbad, USA) and were
transferred to PVDF membranes (Bio-Rad, Hercules, USA).
Membranes were blocked with 4% fat-free milk diluted in PBST
(0,05% Tween-20, 16PBS) for 1 hour at room temperature and
incubated with primary antibodies. Antigen-antibody complexes
were detected by incubating the membrane with the appropriate
secondary antibodies at room temperature for 1 hour. Immuno-
reactive proteins were visualized with enhanced chemilumines-
cence and exposed to autoradiographic film (Amersham, GE
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chemical experiments were performed in HeLa, HEK293 and
U2OS cells (American Type Culture Collection (ATCC): CCL-2,
Manassas, VA). Mitochondria were stained with Mitotracker Red
CMXRos (Molecular Probes; Life Technologies, Carlsbad, USA)
before fixation according to manufacturer’s instructions. In all
experiments cells were fixed with 4% PFA or 2% formaldehyde
for 20 min at room temperature. Cells were then washed three
times with PBS, incubated with primary antibodies (1 hour at
room temperature), washed, incubated with appropriate second-
ary antibodies (1 hour at room temperature), washed and
mounted with Prolong Gold Antifade medium with Dapi (Life
Technologies, Carlsbad, USA). In all experiments, the following
controls were included: (i) to assess possible autofluorescence of
the samples, the primary and secondary antibodies were omitted
in the incubation steps; (ii) to assess possible autofluorescence of
secondary antibodies, the primary antibodies were omitted in
incubation step. Images were acquired using a confocal
microscope Leica SP5. Co-localization of AGO2 with mitochon-
dria was assessed by statistical analysis of the correlation of the
intensity values of green (AGO2) and red (mitochondria) pixels in
dual-channel images. The JACoP plug-in from ImageJ software
was used to calculate the Pearson’s correlation coefficient (rp) and
to perform cross-correlation analysis (Van Steensel’s cross-
correlation function, CCF) [28,66,67]. The Pearson’s correlation
coefficient (rp) describes the correlation of the distributions of
signal intensity of pixels between green and red channels [60]. It
lies between +1 and 21. From 0 to +1, values indicate significant
correlation of green and red images, with 1 indicating 100% co-
localization. In the Van Steensel’s approach, the CCF is
calculated as the value of rp while operating a shift of one of
the images relative to the other, then plotting the retrieved rpa sa
function of the displacement. Co-localization is identified by a
Gaussian distribution, while in the opposite situation, the curve
appears as a hollow.
Co-immunoprecipitation of mitochondrial transcripts
Co-immunoprecipitation of AGO2 with associated transcripts
was performed using mMACS protein A microbeads (Miltenyi-
Biotec, Bergisch Gladbach, Germany) according to manufacturer’s
instructions with the following modifications. Briefly, proteins were
incubated with protein A microbeads and either rabbit polyclonal
anti-AGO2 (clone 7C6 or 7C3) or rabbit polyclonal anti-SLUG as
a negative control (sc-15391X, Santa Cruz Biotechnology, Santa
Cruz, USA) for 1 hour at 4uC on ice. After 6 washes of varying
stringency onto microcolumns, proteins were treated with
proteinase K in washing buffer complemented with 0.1% SDS,
25 mM EDTA for 309 at 42uC. Transcripts were then eluted at
80uC with pre-heated RNase-free water. Subsequently, RNA was
extracted with Trizol reagent (Lifetechnologies, Carlsbad, USA)
(according to manufacturer’s protocol), treated with the RQ1
RNase-free DNase I (Promega, Madison, USA) (according to
manufacturer’s instructions), reverse transcribed with the Gen-
eAmp RNA PCR kit (Applied Biosystems, Life Technologies,
Carlsbad, USA) (according to manufacturers’ instructions), and
subsequently amplified by PCR using standard conditions.
Structural analyses of miRNAs
The minimal folding energy (MFE), expressed in kcal/mol, is a
method of calculating the thermodynamic stability of the
secondary structure of RNA [68]. The lower the MFE of a
molecule, the more stable the secondary structure. Minimal
folding free energies (MFEs) of pre-miRNAs were estimated using
the program RNAfold (Vienna RNA Package, version 2.0.0) with
default parameter values [69,70]. Because MFE values are
strongly correlated with the length of the sequence we normalized
the MFE by calculating the adjusted MFE (AMFE) using the
following equation: AMFE=[(2MFE/length of RNA se-
quence)6100] [71]. MFE index (MFEI) was calculated using the
following equation: MFEI=AMFE/(G+C)% [71].
Computational prediction of miRNA targets
For each miRNA, genome-wide miRNA nuclear targets were
determined using miRDB as a tool of primary focus on mature
miRNAs, which are the functional carriers of miRNA-mediated
regulation of gene expression [72]. Enrichment in mitochondrial
protein-coding gene was identified from the overlap between
predicted targets and mitochondrial proteome [40]. To scan the
mitochondrial genome for potential miRNA target sites, we used
four independent algorithms RNA22, Target Scan, RegRNA and
miRWalk. RegRNA is based on the miRanda algorithm, which
relies on both the complementarity of miRNA and target
sequences and on the conservation of the target site [73]. Target
Scan algorithm (http://www.targetscan.org/) searches for the
presence of conserved target sites that match the seed region of
each miRNA and assesses the structural accessibility of the
predicted target site. RNA22 is based on the Teiresias algorithm,
which relies on a pattern-based approach without using conser-
vation filters [74]. The miRWalk algorithm is based on a
computational approach starting with a heptamer seed of miRNA
and identifies possible complementary on the complete mitochon-
drial genome (Ruprecht-Karls-Universita ¨t Heidelberg, Medizi-
nische Fakulta ¨t Mannheim, Germany). A probability distribution
of random matches of a subsequence (miRNA 59 end sequence) in
the given sequence was calculated by using Poisson distribution
where a low probability implies a significant hit. All predictions
algorithms were run under default parameters.
Expression data and pathway database analysis
All data is MIAME compliant and the data presented in this
manuscript have been deposited in NCBI’s Gene Expression
Omnibus. miRNA expression profiling data was accessed through
mimiRNA [36] and MirZ [35]. The ExParser algorithm [36] was
used to compile datasets of gene that multiple experimental
sources classified as targets of one mitomiR and/or as genes co-
regulated with the mitomiR. The datasets obtained for each
miRNA were uploaded into MetaCore
TM, a systems biology
pathway analysis tool [41]. Ontology enrichment analysis was
performed using general enrichment categories, i.e. Gene
Ontology and GeneGo
TM Processes, which represents prebuilt
networks of manually curated protein-protein, or protein-nucleic
acid interactions, assembled on the basis of proven literature
evidence. The enrichment calculation uses the Fisher exact test or
hypergeometric distribution to calculate the probability that the
degree of overlap between the list of miRNA targets (generated
from the ExParser query), and the protein represented in the
functional ontology category can happen by chance, given an
identical number of proteins selected at random from the protein
universe annotated within the ontology. The p-value generated is
used to rank the functional representation of the miRNA targets in
each ontology by their significance to the list of targets, thereby
identifying biological process likely to be affected. Probabilities
were calculated according to the manufacturer’s recommenda-
tions.
Statistics and microarray analyses
Statistical significance was validated using a two-tailed Student’s
t-test assuming unequal variance, respectively a Fisher-Snedecor
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for p,0.05 in each test. Data analysis of the microarray was
performed as follows: first, scan images of the microarrays were
analyzed using the ImaGene Software (Biodiscovery). During the
image analysis, irregular spots, dust particles or areas of high
background were discarded, and exact position of each spot, its
identity, its signal intensity, and surrounding background are
saved. Second, primary data analysis was then performed
calculating the net signal intensities (spot signal intensity minus
background signal intensity). As filter criteria, we applied the 50%
percentile of the background signal intensities. For calculation of
the Hy5/Hy3 ratio, only spots/genes with signal equal or higher
than the 50% percentile of the background signal intensities were
taken into account. For each microarray this Hy5 and Hy3
default/threshold value was adjusted by the median of the
calibrators. Third, data were normalized to correct for dye bias
such as inconsistent labelling efficiencies, varying quantum yields
of the dyes, or different scanning parameters. To overcome these
systematic variations a normalization using spiked calibration
controls was performed. After normalization, ratios of the
mitochondrial vs. cytosol for each spot were calculated, and
subsequently the mean of the ratio from 4 spots was calculated.
Ratios were calculated for values above the adjusted thres-
hold value (calculated based on the 50% percentile of the
background signal intensities and adjusted by the mean of the
calibration oligos): avg(Hy5-bkg),adjust_Hy5_default AND avg
(Hy3-bkg),adjust_Hy3_default.
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